In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C76H138N2O28 1526.943620 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C76H140N2O28 1528.959270 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C72H130N2O32 1534.860680 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C72H130N2O32 1534.860680 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C72H131NO33 1537.860346 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C76H137N3O28 1539.938869 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C76H139N3O28 1541.954519 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C72H130N2O33 1550.855595 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C72H130N2O33 1550.855595 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O32 1562.891980 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O32 1562.891980 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C74H135NO33 1565.891646 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C78H141N3O28 1567.970169 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C78H143N3O28 1569.985819 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O32 1575.887229 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O33 1578.886895 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C74H134N2O33 1578.886895 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O32 1590.923280 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O32 1590.923280 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(Galβ1-3GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3(GlcNAcβ1-6)GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-4GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C74H133N3O33 1591.882144 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C76H139NO33 1593.922946 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O32 1603.918529 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O33 1606.918195 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C76H138N2O33 1606.918195 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O32 1618.954580 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα2-3Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C78H142N2O32 1618.954580 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(Galβ1-3GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3(GlcNAcβ1-6)GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-4GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C76H137N3O33 1619.913444 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C78H141NO33 1619.938596 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C78H143NO33 1621.954246 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]